NIH-funded research NIH-funded research

Using Vibrational Spectroscopy to Diagnose Fibromyalgia and Related Pain Conditions

Official title: Objective tests utilizing Vibrational Spectroscopy for Diagnosis and Severity of Fibromyalgia and Related Pain Syndromes

Funded at University of Texas at Austin · NIH-11118918 · Data updated 2026-11-12

This study is looking at a new way to help diagnose Fibromyalgia and similar conditions by using special technology to analyze samples from patients, aiming to find clear signs that can help doctors make better decisions and reduce the need for pain medications.

More Fibromyalgia research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Texas at Austin
NIH-funded
Lab location1 site (Austin, United States)
Project startSeptember 15, 2020
Project endMarch 31, 2026
Funding year2025
Award (this year)$569,451
NIH project number5R33NS117211-03
Project IDNIH-11118918 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults over 21 years old who experience chronic widespread pain and may be diagnosed with Fibromyalgia or other central sensitivity syndromes.

Less likely to help

Patients with conditions that do not involve chronic pain or those under 21 years old may not benefit from this research.

What this research studies

This research investigates the use of vibrational spectroscopy as a diagnostic tool for Fibromyalgia (FM) and other central sensitivity syndromes (CSS). By analyzing biological samples, the study aims to identify specific biomarkers that can accurately diagnose FM, which is often misdiagnosed or overlooked. The approach combines both subjective patient reports and objective spectroscopic data to improve diagnosis and treatment options. This innovative methodology seeks to reduce reliance on opioids by providing clearer diagnostic criteria for affected individuals.

Why it matters

Potential benefit: If successful, this research could lead to more accurate diagnoses of Fibromyalgia and related conditions, ultimately improving treatment outcomes for patients.

How similar studies have gone: Previous research has shown promise in using biomarker identification techniques for diagnosing chronic pain conditions, suggesting that this approach may yield successful outcomes.

Where this research is happening

  • University of Texas at Austin
    Austin, United States
    Active

Researchers

  • Principal investigator: Hackshaw, Kevin Victor — University of Texas at Austin
  • Study coordinator: Hackshaw, Kevin Victor

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.